共 50 条
- [21] Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral DosesClinical Drug Investigation, 2020, 40 : 603 - 615Ramakrishna NirogiKoteshwara MudigondaGopinadh BhyrapuneniNageswara Rao MuddanaAnil ShindeVinod Kumar GoyalSantosh Kumar PandeyAbdul Rasheed MohammedJyothsna RavulaSatish JettaVeera Raghava Chowdary Palacharla
- [22] SUVN-G3031, A HISTAMINE H3 RECEPTOR INVERSE AGONIST PRODUCES WAKE PROMOTING AND ANTI-CATAPLECTIC EFFECTS IN HYPOCRETIN-2-SAPORIN LESIONED RATSSLEEP MEDICINE, 2019, 64 : S280 - S280Daripelli, S.Benade, V.Tirumalasetty, C.Subramanian, R.Petlu, S.Badange, R.Nirogi, R.
- [23] Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsyEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 152 : 105425Nirogi, RamakrishnaBhyrapuneni, GopinadhMuddana, Nageswara RaoManoharan, ArunkumarShinde, Anil K.Mohammed, Abdul RasheedPadala, Nagasurya PrakashAjjala, Devender ReddySubramanian, RamkumarPalacharla, Veera Raghava Chowdary
- [24] Discovery and characterization of CEP-26401: A potent, selective histamine H3 receptor inverse agonistABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241Hudkins, Robert L.Raddatz, RitaTao, MingMathiasen, Joanne R.Grunner, John A.Aimone, Lisa D.Prouty, Catherine P.Becknell, Nadine C.Knutsen, LarsYazdanian, MehranMoachon, GilbertAtor, Mark A.Mallamo, John P.Marino, Michael J.Bacon, Edward R.Williams, Michael
- [25] Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsySLEEP MEDICINE, 2024, 124 : 618 - 626Nirogi, RamakrishnaShinde, AnilGoyal, Vinod KumarRavula, JyothsnaBenade, VijayJetta, SatishPandey, Santosh KumarSubramanian, RamkumarPalacharla, Veera Raghava ChowdaryMohammed, Abdul RasheedAbraham, RennyDogiparti, Dhanunjay KumarKalaikadhiban, IlayarajaJayarajan, PradeepJasti, VenkatBogan, Richard K.
- [27] Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (03) : 1203 - 1217Nirogi, RamakrishnaShinde, AnilMohammed, Abdul RasheedBadange, Rajesh KumarReballi, VeenaBandyala, Thrinath ReddySaraf, Sangram KeshariBojja, KumarManchineella, SravanthiAchanta, Pramod KumarKandukuri, Kiran KumarSubramanian, RamkumarBenade, VijayPalacharla, Raghava ChoudaryJayarajan, PradeepPandey, SantoshkumarJasti, Venkat
- [28] Neuropsychiatric applications of BF 2-649, a potent and selective inverse agonist at the histamine H3 receptorINTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S12 - S12Schwartz, J. C.
- [29] Novel amides as potent and selective histamine H3 receptor antagonistsABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242Nirogi, RamakrishnaShinde, AnilKambhampati, RamasastriDeshpande, AmolDwarampudi, AdireddyGangadasari, NarsimhareddyCheppala, AtreyaRambabu, NamalaKandikere, VishwottamJayarajan, PradeepMuddana, NageswararaoAhmad, Ishtiyaque
- [30] Design and Evaluation of Novel Biphenyl Sulfonamide Derivatives with Potent Histamine H3 Receptor Inverse Agonist ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (18) : 5603 - 5611Covel, Jonathan A.Santora, Vincent J.Smith, Jeffrey M.Hayashi, RenaGallardo, CharlemagneWeinhouse, Michael I.Ibarra, Jason B.Schultz, Jeffrey A.Park, Douglas M.Estrada, Scott A.Hofilena, Brian J.Pulley, Michelle D.Smith, Brian M.Ren, AlbertSuarez, MarissaFrazer, JohnEdwards, JeffreyHauser, Erin K.Lorca, JodieSemple, GraemeGrottick, Andrew J.